AI-generated summary
The authors report two case reports of patients with early acute infectious respiratory syndrome treated with photobiomodulation using 630 and 660 nm light applied over the chest. They describe alleviation of respiratory symptoms, reduced pulmonary inflammation and hypoxia, and suggest the approach could prevent more severe respiratory distress. The authors note that their clinical experience could serve as a basis for future research.
- Who or what was studied
- Two patients with early acute infectious respiratory syndrome
- Wavelengths
- 630, 660 nm
- Limits stated in the abstract
- The study consists of only two case reports, so the findings cannot be generalized and no control group or formal outcome measurement is described in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Inflammation, Case report. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.